We are live on ! Find out more
SBIO icon

ALPS Medical Breakthroughs ETF

52 hedge funds and large institutions have $60.8M invested in ALPS Medical Breakthroughs ETF in 2020 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 15 increasing their positions, 13 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

15% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 13

1.41% more ownership

Funds ownership: 32.98%34.39% (+1.4%)

3% less capital invested

Capital invested by funds: $62.7M → $60.8M (-$1.93M)

8% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 12

2% less funds holding

Funds holding: 5352 (-1)

Holders
52
Holders Change
-1
Holders Change %
-1.89%
% of All Funds
1.05%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
11
Increased
15
Reduced
13
Closed
12
Calls
$1.36M
Puts
Net Calls
+$1.36M
Net Calls Change
-$219K

SBIO Hedge Fund Activity: Q3 2020 in Review

52 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in ALPS Medical Breakthroughs ETF (SBIO) for Q3 2020, worth a combined $60.8M — down 3.1% from $62.7M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of SBIO and 11 opened new positions — a net loss of 1 holder — while 13 trimmed existing stakes and 15 added.

The largest buyer was Tower Research Capital (TRC), adding an estimated $1.71M. The largest seller was Morgan Stanley, cutting an estimated $1.04M.

  • 52 institutional investors held ALPS Medical Breakthroughs ETF (SBIO) as of Q3 2020, down from 53 in Q2 2020.
  • Funds reported $60.8M of ALPS Medical Breakthroughs ETF stock for Q3 2020, down 3.1% quarter-over-quarter.
  • 11 funds opened new ALPS Medical Breakthroughs ETF positions in Q3 2020 and 12 closed out, a net change of -1 holder.
  • The largest ALPS Medical Breakthroughs ETF buyer in Q3 2020 was Tower Research Capital (TRC), an estimated $1.71M added.
  • The largest ALPS Medical Breakthroughs ETF seller in Q3 2020 was Morgan Stanley, an estimated $1.04M sold.

Based on aggregated 13F filings for Q3 2020.